Competition & Markets Authority
CMA and Monitor publish guidance on the competition review of NHS mergers
The Competition and Markets Authority (CMA) and Monitor have jointly published a short guide on the competition review of NHS mergers.
The guide will help merging providers navigate the review process. It covers the respective roles of the CMA and Monitor, whether and when to notify them about a merger, the stages of review, how the merger review assesses competition and where patient benefits are considered. It is designed as a short introductory guide and is supported by more detailed guidance produced by the 2 bodies.
It also stresses the importance of early engagement with Monitor when considering a merger or similar strategic option and how both Monitor and the CMA can provide informal advice for providers during the early stages of the process.
Alex Chisholm, CMA Chief Executive, said:
We understand this is still new territory for NHS providers and so we want to do all that we can to ensure that they understand the process and know what to expect. That way we can help things run as quickly and efficiently as possible. Both of our organisations are focussed on ensuring that patient interests are the deciding factor in planning NHS mergers.
The CMA has also published longer and more detailed guidance on how it reviews NHS mergers, aimed at legal and financial advisors working for merging parties. A draft version of this document was published in May and the final version incorporates changes made as a result of the responses received. Monitor has also published more detailed guidance on transactions and how it assesses merger benefits.
Notes for editors
- The CMA is the UK’s primary competition and consumer authority. It is an independent non-ministerial government department with responsibility for carrying out investigations into mergers, markets and the regulated industries and enforcing competition and consumer law. From 1 April 2014 it took over the functions of the Competition Commission and the competition and certain consumer functions of the Office of Fair Trading, as amended by the Enterprise and Regulatory Reform Act 2013. For more information see the CMA’s homepage.
- Monitor is the sector regulator of health care services. Under the Health and Social Care Act 2012 its main duty is to protect and promote the interests of people who use them. More information about Monitor’s role. As sector regulator, it makes sure patients do not lose out through restrictions on their rights to make choices, through poor purchasing on their behalf, or through inappropriate anti-competitive behaviour by providers or commissioners.
- For CMA updates, follow us on Twitter @CMAgovuk, Flickr andLinkedIn.
- Enquiries should be directed to Michael Rosen on 020 3738 6133
Latest News from
Competition & Markets Authority
CMA disqualifies pharma director11/01/2022 13:25:00
The CMA has secured the disqualification of a pharmaceutical company director, in connection with his involvement in illegal anti-competitive practices.
CMA Chief Executive confirms plan to step down in July 202206/01/2022 15:10:00
CMA Chief Executive Andrea Coscelli has confirmed he will step down from the role at the end of his current term in July 2022.
CMA action frees leaseholders from costly contract terms23/12/2021 09:15:00
Following CMA action, leaseholders with Taylor Wimpey will no longer be subjected to ground rents that double every 10 years.
CMA provisionally finds lighting firm illegally banned discounts17/12/2021 12:20:00
The CMA has provisionally found that Dar Lighting Limited has broken competition law by preventing retailers from offering discounts online.
Apple and Google duopoly limits competition and choice14/12/2021 12:15:00
The CMA’s interim report into mobile ecosystems suggests that users are losing out because of Apple and Google’s duopoly.
Dye & Durham’s purchase of TM Group could reduce competition09/12/2021 12:20:00
The CMA has found that Dye & Durham’s purchase of TM Group raises competition concerns and may now be referred for an in-depth investigation.
CMA finds Veolia / Suez merger raises competition concerns07/12/2021 12:20:00
The CMA has found that the merger of Veolia and Suez could lead to a loss of competition in the supply of several waste and water management services in the UK.
Joint Statement from UK Competition and Markets Authority, U.S. FTC and DOJ Antitrust Division leadership following the G7 Competition Enforcers Summit03/12/2021 16:35:00
Leadership of the Federal Trade Commission and the Antitrust Division of the Department of Justice attended meetings in London this week as part of the Competition Enforcers Summit, which took place under the 2021 G7 Digital and Technology Track in connection with the UK’s G7 presidency.